Latest Stocks: US Bancorp DE Sells 1,471 Shares of Neogen Co. (NEOG)

Latest Stocks: US Bancorp DE Sells 1,471 Shares of Neogen Co. (NEOG)

US Bancorp DE lowered its stake in shares of Neogen Co. (NASDAQ:NEOG) by 3.8% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 37,269 shares of the company’s stock after selling 1,471 shares during the period. US Bancorp DE owned 0.10% of Neogen worth $2,443,000 at the end of the most recent quarter.

Several other institutional investors have also added to or reduced their stakes in the stock. Norges Bank acquired a new position in Neogen during the fourth quarter valued at approximately $44,409,000. Brown Capital Management LLC raised its position in Neogen by 5.8% in the fourth quarter. Brown Capital Management LLC now owns 5,368,547 shares of the company’s stock valued at $354,324,000 after buying an additional 293,241 shares in the last quarter. Russell Investments Group Ltd. acquired a new position in Neogen during the fourth quarter valued at approximately $3,382,000. Legato Capital Management LLC raised its position in Neogen by 6,455.1% in the first quarter. Legato Capital Management LLC now owns 45,951 shares of the company’s stock valued at $701,000 after buying an additional 45,250 shares in the last quarter. Finally, State Street Corp raised its position in Neogen by 5.0% in the fourth quarter. State Street Corp now owns 832,167 shares of the company’s stock valued at $54,925,000 after buying an additional 39,382 shares in the last quarter. 83.47% of the stock is currently owned by institutional investors.

Shares of Neogen Co. (NASDAQ NEOG) opened at 64.39 on Tuesday. The stock has a market cap of $2.45 billion, a PE ratio of 59.62 and a beta of 1.55. Neogen Co. has a 12 month low of $50.24 and a 12 month high of $69.09. The firm’s 50-day moving average is $62.39 and its 200 day moving average is $64.09.

Separately, Zacks Investment Research raised shares of Neogen from a “hold” rating to a “buy” rating and set a $73.00 target price on the stock in a report on Thursday, March 23rd. In other news, CFO Steven J. Quinlan sold 2,676 shares of Neogen stock in a transaction dated Thursday, April 27th. The stock was sold at an average price of $63.68, for a total value of $170,407.68. Following the completion of the transaction, the chief financial officer now owns 12,779 shares in the company, valued at approximately $813,766.72. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CEO James L. Herbert sold 8,107 shares of Neogen stock in a transaction dated Thursday, May 11th. The shares were sold at an average price of $62.01, for a total value of $502,715.07. Following the completion of the transaction, the chief executive officer now owns 890,319 shares of the company’s stock, valued at approximately $55,208,681.19. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 85,270 shares of company stock valued at $5,243,885. 4.70% of the stock is currently owned by corporate insiders.

Receive News & Ratings for Neogen Co. Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Neogen Co. and related companies with MarketBeat.com’s FREE daily email newsletter.

Related posts

Leave a Comment